2-Tolylboronic Acid Bulk Price Factory Supply 2026

• Competitive Factory Direct Pricing: Optimized cost structures for kilogram to ton-scale procurement.
• High Industrial Purity: Consistent assay results exceeding 94% via HPLC analysis.
• Reliable Global Logistics: Secure packaging and compliant shipping for hazardous chemical intermediates.

In the landscape of modern medicinal chemistry and process development, the availability of high-quality organoboron compounds is critical for efficient cross-coupling reactions. As we approach 2026, the demand for reliable factory supply chains remains a priority for pharmaceutical manufacturers and CROs. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer dedicated to providing consistent quality and competitive pricing for essential building blocks. This article details the technical specifications, pricing tiers, and market analysis for this key intermediate.

Bulk Pricing Tiers for Chemical Intermediates

Procurement strategies for fine chemicals often depend on volume commitments. Understanding the cost structure is essential for budgeting large-scale synthesis campaigns. The pricing for organoboron reagents fluctuates based on raw material availability, energy costs, and purification requirements. Below is a indicative pricing structure based on current market conditions and projected 2026 trends.

Quantity Tier	Packaging Format	Estimated Unit Price Trend	Lead Time
100g - 1kg	Glass Bottle / Aluminum Foil	Premium (R&D Scale)	3-5 Days
1kg - 25kg	Drum / Cardboard Box	Standard Pilot Scale	7-10 Days
25kg - 100kg	Fiber Drum	Bulk Discount Applied	10-15 Days
100kg+	Custom Bulk Packaging	Contract Manufacturing Rate	Negotiated

These tiers reflect the economies of scale achievable when sourcing directly from a production facility rather than through secondary distributors. For projects requiring strict quality control, requesting a Certificate of Analysis (COA) is standard practice to verify assay percentages and impurity profiles.

Factory Supply MOQ and Lead Times

Minimum Order Quantity (MOQ) policies are designed to balance production efficiency with customer flexibility. For specialized intermediates like (2-methylphenyl)boronic acid, manufacturers often set lower MOQs for research-grade materials while incentivizing larger orders for production batches. Efficient factory supply chains minimize lead times by maintaining strategic stock levels of raw materials.

Typical packaging for bulk orders involves double-lined polyethylene bags within fiber drums to ensure stability during transit. Safety is paramount; therefore, all shipments comply with international hazardous goods regulations. The product typically presents as a beige to off-white solid. Proper handling requires adherence to safety data sheets, noting that the material may cause serious eye irritation and should be handled with protective equipment to avoid respiratory exposure.

When evaluating specifications for 2-Tolylboronic acid, procurement managers should verify the melting point range, which is typically observed between 164.0°C and 165.0°C. Deviations from this range may indicate solvent retention or the presence of isomeric impurities. Consistent batch-to-batch reproducibility is a hallmark of a reliable partner in the chemical supply chain.

2026 Market Cost Analysis and FOB Terms

Looking toward 2026, the market cost analysis suggests a stabilization in pricing for boronic acid derivatives, assuming raw material supply chains for boric acid and ortho-tolyl halides remain robust. FOB (Free on Board) terms are commonly utilized for international transactions, placing the responsibility on the buyer once goods are loaded onto the vessel. This allows buyers to control freight logistics and insurance costs.

Several factors will influence the bulk price in the coming years:

• Energy Costs: Synthesis and purification processes are energy-intensive.
• Regulatory Compliance: Increasing environmental standards may impact manufacturing overheads.
• Demand Growth: Expansion in oncology and immunology drug discovery drives consumption.

Strategic forecasting allows companies to lock in rates before market shifts occur. Engaging with suppliers early in the development cycle ensures that scale-up processes are not hindered by material shortages.

Technical Specifications and Synthesis Route

The synthesis route for this compound typically involves the reaction of an ortho-tolyl halide with a boron source, such as trialkyl borate, followed by hydrolysis. Achieving high industrial purity requires rigorous recrystallization or chromatographic purification to remove homocoupling byproducts and unreacted starting materials. The final assay should be verified via HPLC, with a standard acceptance criterion of 94% minimum purity for general synthetic applications.

As a versatile Suzuki coupling reagent, this molecule is indispensable for constructing biaryl motifs found in numerous active pharmaceutical ingredients (APIs). The ortho-methyl group introduces steric hindrance that can influence the conformational landscape of the final drug molecule, potentially improving binding affinity or metabolic stability. This intermediate is frequently utilized in the synthesis of compounds targeting complex biological pathways, including Kinases, GPCRs, and various enzymes involved in cell cycle regulation and apoptosis.

Researchers utilizing this building block often explore libraries targeting Protein Tyrosine Kinases or Nuclear Receptors. The chemical stability of the boronic acid moiety allows for diverse downstream transformations, making it a staple in modular synthesis approaches. Ensuring the water content is minimized is crucial, as excessive moisture can lead to protodeboronation during storage or reaction setup.

Conclusion and Procurement Strategy

Securing a stable supply of high-quality intermediates is fundamental to successful drug development. By prioritizing partners who offer transparent COAs, competitive FOB terms, and robust technical support, organizations can mitigate supply chain risks. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to supporting the global pharmaceutical industry with reliable manufacturing capabilities and precise chemical solutions.

For upcoming projects requiring scalable quantities, early engagement with the supply team is recommended to align production schedules with clinical trial timelines. Whether for early-stage discovery or commercial manufacturing, selecting the right grade and supplier ensures project continuity and cost-efficiency.